🇺🇸 FDA
Patent

US 10478448

Methods and compositions for modulating apolipoprotein (a) expression

granted A61KA61K31/7115A61K31/712

Quick answer

US patent 10478448 (Methods and compositions for modulating apolipoprotein (a) expression) held by Ionis Pharmaceuticals, Inc. expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/7115, A61K31/712, A61K31/7125